Eyenovia Inc (EYEN)

NASDAQ
1.940
-0.030(-1.52%)
  • Volume:
    21,607
  • Day's Range:
    1.930 - 2.012
  • 52 wk Range:
    1.520 - 4.210

EYEN Overview

Prev. Close
1.97
Day's Range
1.93-2.012
Revenue
10M
Open
1.97
52 wk Range
1.52-4.21
EPS
-0.599
Volume
21,607
Market Cap
70.06M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
292,128
P/E Ratio
-3.05
Beta
1.61
1-Year Change
-47.47%
Shares Outstanding
36,112,987
Next Earnings Date
Mar 29, 2023
What is your sentiment on Eyenovia?
or
Vote to see community's results!

Eyenovia Inc News

Eyenovia Inc Analysis

Eyenovia Inc Company Profile

Eyenovia Inc Company Profile

Employees
44

Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the development of therapeutic indications for patients with progressive myopia and age-related near vision impairment or presbyopia indications; and microdose fixed combination ophthalmic pharmaceutical for mydriasis to address the eye exams with pupil dilation. The company’s product candidates include MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); and MydCombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; and a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine and MicroLine in China and South Korea. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is headquartered in New York, New York.

Read More

Analyst Price Target

Average14.333 (+638.83% Upside)
High16
Low12
Price1.94
No. of Analysts3
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuyBuySell
Technical IndicatorsSellStrong SellStrong BuyStrong BuyStrong Sell
SummaryNeutralNeutralStrong BuyStrong BuyStrong Sell
  • https://www.reddit.com/r/MicrocapStocksRun/comments/pfs8ib/5_biotech_stocks_insiders_are_buying/?utm_source=share&utm_medium=web2x&context=3
    0
    • I hate pump and dumps like this which pull back, start to go back up and then drop like a rock once your in!
      0
      • Bought at 10 with director trading , happy to get out at 6 . Will rebuy at 2.50 soon .
        1
        • so you sold at a loss?
          0
        • It cost $10 only in the very beginning in Janury 2018 so you got this stock as salary package, right ?
          0